[1]JournalofMedicinalChemistry,2013,vol.56,#21,p.8931-8942
[1]JournalofMedicinalChemistry,2013,vol.56,#21,p.8931-8942
[1]JournalofMedicinalChemistry,2013,vol.56,#21,p.8931-8942
[1]JournalofMedicinalChemistry,2013,vol.56,#21,p.8931-8942
[1]JournalofMedicinalChemistry,2013,vol.56,#21,p.8931-8942
[1]JournalofMedicinalChemistry,2013,vol.56,p.8931-8942
Title: YM155 as an inhibitor of cancer stemness simultaneously inhibits autophosphorylation of epidermal growth factor receptor and G9a-mediated stemness in lung cancer cells.
Journal: PloS one 20170101
Title: Discovery of an in vivo chemical probe of the lysine methyltransferases G9a and GLP.
Journal: Journal of medicinal chemistry 20131114
Title: Job satisfaction in a chronic care facility.
Journal: Dimensions in health service 19760101
Title: Liu F, et al. Discovery of an in vivo chemical probe of the lysine methyltransferases G9a and GLP. J Med Chem. 2013 Nov 14;56(21):8931-8942.
Title: Wang L, et al. Targeting EHMT2 reverses EGFR-TKI resistance in NSCLC by epigenetically regulating the PTEN/AKT signaling pathway. Cell Death Dis. 2018 Jan 26;9(2):129
